Drug safety agency is accused of cover-up
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The chief executive of the mental health charity Mind resigned from an expert working party on antidepressants last night in a row over doctor's prescribing unsafe doses of the drug. Richard Brook resigned accusing drug regulators of negligence in suppressing 10-year-old evidence that Seroxat was being prescribed in dangerously high quantities.
Mr Brook said the group had told the government's advisory Committee on the Safety of Medicines in October of their concerns, and this week the CSM issued "a reminder" to doctors of Seroxat's recommended dose of 20mg. Last year around 17,000 people were told by their doctors to take higher doses of the drug, whose side effects can include violent impulses and agitation.
In his letter of resignation, Mr Brook said that said crucial dosage data had been known to the Medicine and Healthcare Products Regulatory Agency, which licences drugs on advice from the CSM, since 1990.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments